EARNEST Partners’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $51.3M | Sell |
3,055,996
-165,047
| -5% | -$2.95M | 0.21% | 153 |
|
|
2025
Q4 | $51.6M | Sell |
3,221,043
-206,616
| -6% | -$3.08M | 0.22% | 153 |
|
|
2025
Q3 | $42.4M | Sell |
3,427,659
-175,370
| -5% | -$2.06M | 0.18% | 156 |
|
|
2025
Q2 | $41.5M | Sell |
3,603,029
-27,250
| -0.8% | -$323K | 0.19% | 156 |
|
|
2025
Q1 | $54.4M | Sell |
3,630,279
-54,441
| -1% | -$911K | 0.26% | 136 |
|
|
2024
Q4 | $63.8M | Sell |
3,684,720
-71,998
| -2% | -$1.39M | 0.29% | 127 |
|
|
2024
Q3 | $69.6M | Buy |
3,756,718
+470,280
| +14% | +$9.44M | 0.3% | 128 |
|
|
2024
Q2 | $66.7M | Buy |
3,286,438
+195,756
| +6% | +$3.46M | 0.31% | 125 |
|
|
2024
Q1 | $52.8M | Sell |
3,090,682
-636,986
| -17% | -$10M | 0.24% | 147 |
|
|
2023
Q4 | $65.8M | Sell |
3,727,668
-53,944
| -1% | -$1.09M | 0.33% | 117 |
|
|
2023
Q3 | $90.8M | Sell |
3,781,612
-53,826
| -1% | -$1.32M | 0.52% | 77 |
|
|
2023
Q2 | $89.2M | Buy |
3,835,438
+271,963
| +8% | +$6.15M | 0.5% | 83 |
|
|
2023
Q1 | $78.6M | Sell |
3,563,475
-9,626
| -0.3% | -$225K | 0.45% | 96 |
|
|
2022
Q4 | $72.4M | Buy |
3,573,101
+258,817
| +8% | +$5.02M | 0.44% | 98 |
|
|
2022
Q3 | $44.7M | Buy |
3,314,284
+10,709
| +0.3% | +$180K | 0.3% | 118 |
|
|
2022
Q2 | $65.4M | Sell |
3,303,575
-97,562
| -3% | -$2.59M | 0.44% | 95 |
|
|
2022
Q1 | $108M | Sell |
3,401,137
-32,293
| -0.9% | -$905K | 0.64% | 64 |
|
|
2021
Q4 | $76.6M | Sell |
3,433,430
-158,864
| -4% | -$4.14M | 0.44% | 88 |
|
|
2021
Q3 | $99.7M | Sell |
3,592,294
-263,747
| -7% | -$8.03M | 0.61% | 60 |
|
|
2021
Q2 | $150M | Sell |
3,856,041
-431,187
| -10% | -$15.5M | 0.88% | 38 |
|
|
2021
Q1 | $123M | Buy |
4,287,228
+20,480
| +0.5% | +$700K | 0.74% | 52 |
|
|
2020
Q4 | $113M | Buy |
4,266,748
+83,652
| +2% | +$1.71M | 0.78% | 49 |
|
|
2020
Q3 | $63.8M | Buy |
4,183,096
+503,379
| +14% | +$10.6M | 0.55% | 82 |
|
|
2020
Q2 | $74.8M | Buy |
3,679,717
+716,563
| +24% | +$12.8M | 0.71% | 60 |
|
|
2020
Q1 | $30.6M | Buy |
2,963,154
+29,038
| +1% | +$812K | 0.35% | 99 |
|
|
2019
Q4 | $111M | Buy |
2,934,116
+55,653
| +2% | +$2.5M | 0.87% | 38 |
|
|
2019
Q3 | $134M | Buy |
2,878,463
+569,924
| +25% | +$26.5M | 1.21% | 13 |
|
|
2019
Q2 | $121M | Buy |
2,308,539
+377,223
| +20% | +$22.1M | 1.09% | 18 |
|
|
2019
Q1 | $133M | Buy |
1,931,316
+23,662
| +1% | +$1.59M | 1.27% | 12 |
|
|
2018
Q4 | $114M | Sell |
1,907,654
-29,148
| -2% | -$2.52M | 1.24% | 16 |
|
|
2018
Q3 | $224M | Sell |
1,936,802
-15,736
| -0.8% | -$1.78M | 2.01% | 2 |
|
|
2018
Q2 | $246M | Buy |
1,952,538
+3,795
| +0.2% | +$462K | 2.31% | 2 |
|
|
2018
Q1 | $211M | Sell |
1,948,743
-3,355
| -0.2% | -$371K | 1.99% | 2 |
|
|
2017
Q4 | $214M | Buy |
1,952,098
+379
| +0% | +$37.8K | 2.05% | 2 |
|
|
2017
Q3 | $193M | Buy |
1,951,719
+115,982
| +6% | +$11.2M | 1.92% | 2 |
|
|
2017
Q2 | $186M | Sell |
1,835,737
-8,194
| -0.4% | -$883K | 1.95% | 3 |
|
|
2017
Q1 | $213M | Sell |
1,843,931
-22,519
| -1% | -$2.62M | 2.27% | 2 |
|
|
2016
Q4 | $224M | Sell |
1,866,450
-74,525
| -4% | -$8.25M | 2.45% | 2 |
|
|
2016
Q3 | $218M | Sell |
1,940,975
-81,169
| -4% | -$9.35M | 2.29% | 3 |
|
|
2016
Q2 | $251M | Sell |
2,022,144
-342,918
| -14% | -$41.4M | 2.72% | 2 |
|
|
2016
Q1 | $266M | Sell |
2,365,062
-130,242
| -5% | -$13.5M | 2.79% | 4 |
|
|
2015
Q4 | $271M | Sell |
2,495,304
-80,387
| -3% | -$9.2M | 2.77% | 3 |
|
|
2015
Q3 | $257M | Sell |
2,575,691
-7,183
| -0.3% | -$781K | 2.53% | 3 |
|
|
2015
Q2 | $295M | Buy |
2,582,874
+43,043
| +2% | +$5.22M | 2.57% | 3 |
|
|
2015
Q1 | $265M | Sell |
2,539,831
-135,392
| -5% | -$14.4M | 2.28% | 3 |
|
|
2014
Q4 | $322M | Buy |
2,675,223
+33,521
| +1% | +$4.4M | 2.64% | 3 |
|
|
2014
Q3 | $387M | Sell |
2,641,702
-88,711
| -3% | -$13.7M | 3.23% | 1 |
|
|
2014
Q2 | $456M | Sell |
2,730,413
-38,901
| -1% | -$6.92M | 3.63% | 1 |
|
|
2014
Q1 | $550M | Sell |
2,769,314
-89,488
| -3% | -$16.9M | 4.41% | 1 |
|
|
2013
Q4 | $546M | Buy |
+2,858,802
| New | +$532M | 4.38% | 1 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
EARNEST Partners's CLB Position: Q1 2026 in Review
EARNEST Partners reduced its Core Laboratories (CLB) stake by 5.1% in Q1 2026, selling an estimated $2.95M and leaving 3,055,996 shares worth $51.3M. The position accounts for 0.21% of the portfolio, ranked #153.
EARNEST Partners first reported a position in CLB in Q4 2013 and has held it in 50 quarters since. The position peaked at $550M in Q1 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- EARNEST Partners held 3,055,996 shares of Core Laboratories worth $51.3M as of Q1 2026.
- EARNEST Partners sold 165,047 Core Laboratories shares in Q1 2026, an estimated $2.95M.
- Core Laboratories made up 0.21% of EARNEST Partners's portfolio in Q1 2026, its #153 holding.
- EARNEST Partners first reported a position in Core Laboratories in Q4 2013 and has held it in 50 quarters since.
- EARNEST Partners's Core Laboratories position peaked at $550M in Q1 2014.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on EARNEST Partners's 13F filing for Q1 2026, filed 15 May 2026.